WinstonCAMenziesHJ. Pediatric and adolescent tuberculosis in the United States, 2008-2010. Pediatrics. 2012;130:e1425-e1432.
2.
American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161(4 pt 2):S221-S247.
3.
Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Morbid Mortal Wkly Rep. 2010;59:1-13.
4.
Centers for Disease Control and Prevention. Trends in tuberculosis—United States, 2012. MMWR Morbid Mortal Wkly Rep. 2013;62:201-205.
5.
MahanCSJohnsonDFCurleyCvan der KuypF. Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guérin vaccinated persons. Int J Tuberc Lung Dis. 2011;15:174-178.
6.
HsuKH. Atypical mycobacterial infections in children. Rev Infect Dis. 1981;3:1075-1080.
7.
Haimi-CohenYZehariaAMimouniMSoukhmanMAmirJ. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis. 2001;33:1786-1788.
8.
BierrenbachALCunhaSSBarretoMPereiraSMRodriguesLC. Skin reactivity to mycobacterial antigens parallels the phylogenetic structure of their genus. Int J Tuberc Lung Dis. 2001;5:656-663.
9.
KhanKWangJMarrasTK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med. 2007;176:306-313.
10.
RitzNYauCConnellTGTebrueggeMLeslieDCurtisN. Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis. 2011;15:767-769.
11.
OxladeOSchwartzmanKMenziesD. Interferon gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11:16-26.
